Total Payments
$131,230
2024 Payments
$28,197
Companies
41
Transactions
986
Medicare Patients
2,329
Medicare Billing
$199,529
Payment Breakdown by Category
Other$103,358 (78.8%)
Food & Beverage$13,975 (10.6%)
Travel$12,988 (9.9%)
Consulting$890.00 (0.7%)
Education$19.89 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $103,358 | 48 | 78.8% |
| Food and Beverage | $13,975 | 893 | 10.6% |
| Travel and Lodging | $12,988 | 42 | 9.9% |
| Consulting Fee | $890.00 | 2 | 0.7% |
| Education | $19.89 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $95,387 | 237 | $0 (2024) |
| ABBVIE INC. | $19,496 | 263 | $0 (2024) |
| Madrigal Pharmaceuticals | $9,134 | 9 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,606 | 123 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,093 | 96 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $849.27 | 10 | $0 (2024) |
| Janssen Biotech, Inc. | $522.05 | 41 | $0 (2024) |
| GENZYME CORPORATION | $420.58 | 18 | $0 (2024) |
| PFIZER INC. | $238.92 | 16 | $0 (2024) |
| Shire North American Group Inc | $203.50 | 12 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $28,197 | 168 | Gilead Sciences, Inc. ($16,847) |
| 2023 | $13,293 | 137 | Gilead Sciences, Inc. ($11,588) |
| 2022 | $12,474 | 90 | Gilead Sciences, Inc. ($11,370) |
| 2021 | $9,582 | 38 | Gilead Sciences, Inc. ($9,233) |
| 2020 | $8,248 | 50 | Gilead Sciences, Inc. ($7,892) |
| 2019 | $23,843 | 183 | Gilead Sciences, Inc. ($12,335) |
| 2018 | $18,786 | 172 | Gilead Sciences, Inc. ($12,564) |
| 2017 | $16,807 | 148 | Gilead Sciences Inc ($13,557) |
All Payment Transactions
986 individual payment records from CMS Open Payments — Page 1 of 40
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $9.45 | General |
| Category: Gastroenterology | ||||||
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $1.69 | General |
| Category: Gastroenterology | ||||||
| 12/19/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $27.75 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $1.89 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/16/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $12.02 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/11/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,173.00 | General |
| Category: LIVER DISEASE | ||||||
| 12/11/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | In-kind items and services | $127.96 | General |
| Category: LIVER DISEASE | ||||||
| 12/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/09/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/01/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: GI | ||||||
| 11/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Immunology | ||||||
| 11/21/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $9.54 | General |
| Category: GI | ||||||
| 11/19/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/15/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/12/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $25.92 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/07/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $10.13 | General |
| Category: Gastroenterology | ||||||
| 11/01/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $12.89 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 589 | 620 | $318,528 | $57,898 |
| 2022 | 15 | 551 | 587 | $251,698 | $46,579 |
| 2021 | 17 | 646 | 681 | $271,716 | $53,944 |
| 2020 | 16 | 543 | 564 | $211,030 | $41,108 |
Total Patients
2,329
Total Services
2,452
Medicare Billing
$199,529
Procedure Codes
73
All Medicare Procedures & Services
73 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 154 | 180 | $20,160 | $11,030 | 54.7% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Office | 2023 | 34 | 34 | $28,016 | $6,129 | 21.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Office | 2023 | 29 | 29 | $31,204 | $5,992 | 19.2% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Office | 2023 | 30 | 30 | $24,720 | $5,397 | 21.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2023 | 52 | 52 | $49,816 | $4,135 | 8.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 45 | 45 | $7,425 | $3,854 | 51.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 32 | 32 | $10,080 | $3,727 | 37.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2023 | 26 | 26 | $34,034 | $3,562 | 10.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 16 | 16 | $17,216 | $3,150 | 18.3% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 35 | 36 | $31,644 | $2,881 | 9.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 13 | 13 | $17,017 | $1,918 | 11.3% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2023 | 21 | 21 | $18,459 | $1,560 | 8.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 16 | 16 | $15,328 | $1,405 | 9.2% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Office | 2023 | 11 | 11 | $8,431 | $1,141 | 13.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $2,004 | $804.87 | 40.2% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 16 | 20 | $1,500 | $785.20 | 52.3% |
| 91200 | Measurement of liver stiffness | Office | 2023 | 14 | 14 | $1,078 | $285.03 | 26.4% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Office | 2023 | 33 | 33 | $396.00 | $139.52 | 35.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 149 | 180 | $20,160 | $10,540 | 52.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Office | 2022 | 34 | 34 | $36,584 | $6,251 | 17.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Office | 2022 | 30 | 30 | $24,720 | $5,529 | 22.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 44 | 44 | $7,260 | $3,721 | 51.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2022 | 37 | 37 | $35,446 | $2,894 | 8.2% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Office | 2022 | 15 | 15 | $12,360 | $2,768 | 22.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2022 | 16 | 16 | $20,944 | $2,251 | 10.7% |
About Dr. Michael Basista, M.D
Dr. Michael Basista, M.D is a Gastroenterology healthcare provider based in Sylvania, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/03/2005. The National Provider Identifier (NPI) number assigned to this provider is 1548257876.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Basista, M.D has received a total of $131,230 in payments from pharmaceutical and medical device companies, with $28,197 received in 2024. These payments were reported across 986 transactions from 41 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($103,358).
As a Medicare-enrolled provider, Basista has provided services to 2,329 Medicare beneficiaries, totaling 2,452 services with total Medicare billing of $199,529. Data is available for 4 years (2020–2023), covering 73 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Sylvania, OH
- Active Since 10/03/2005
- Last Updated 11/03/2023
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1548257876
Products in Payments
- Epclusa (Drug) $71,554
- Mavyret (Drug) $14,381
- REZDIFFRA (Drug) $9,132
- Vosevi (Drug) $4,198
- Viekira (Drug) $2,093
- ENTYVIO (Biological) $852.99
- Humira (Biological) $786.36
- OCALIVA (Drug) $764.69
- XIFAXAN (Drug) $636.29
- Entyvio (Biological) $610.36
- RINVOQ (Biological) $464.92
- DUPIXENT (Biological) $444.12
- SKYRIZI (Biological) $436.98
- CREON (Drug) $434.31
- STELARA (Biological) $416.89
- GATTEX (Drug) $334.07
- XIFAXANIBSD (Drug) $302.69
- LINZESS (Drug) $292.52
- TRULANCE (Drug) $259.84
- XELJANZ (Drug) $238.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Sylvania
Thomas Colturi, M.d, M.D
Gastroenterology — Payments: $141,408
Gastroenterology $141,408
Charles Filipiak, Md, MD
Gastroenterology — Payments: $7,077
Gastroenterology $7,077
Kurt Bernsdorff, M.d, M.D
Gastroenterology — Payments: $1,829
Gastroenterology $1,829
Dr. Sara Stanley, D.o, D.O
Gastroenterology — Payments: $1,015
Gastroenterology $1,015